Thank you for the invitation.
In six months, 80 Canadian deaths have been linked to swine flu, also known as H1N1. During that time, almost 20,000 have been linked to diabetes. Immunologist Bart Classen, MD, MBA, provides evidence that vaccines may cause or contribute to both type 1 and type 2 diabetes. Even if vaccines were the source of only 1% of all diabetes cases, they would be much more lethal than H1N1 has been. Unsurprisingly, most of those who have been seriously ill or died from the swine flu have had underlying conditions like diabetes. VRAN contends that it would have been logical to focus most resources on the underlying conditions rather than the virus.
Categories of people highly recommended to have the vaccine include infants, pregnant women, and those with immune-suppressing health conditions. In his article, “Swine Flu: To Vaccinate or Not?”, Marc Girard, MSc, MD, consultant in drug monitoring and pharmaco-epidemiology, declares this to be criminal nonsense. Those are exactly the categories that are most likely to experience vaccine adverse events.
The Public Health Agency of Canada has reassured the public that the vaccine will be safe, when it cannot possibly know that this is true. This summer Dr. Elwyn Griffiths, director general of the biologies and genetic therapies directorate, revealed that a vaccine trial of a mere 100 to 200 Canadians would be enough to allow approval of the vaccine. I don't care what Dr. Griffiths says; I think Canadians need to be trialed, not somebody from Europe, Australia, or wherever. In fact, the trials had just begun the week the vaccine was approved, the week immediately before the first dose might be injected.
The GSK adjuvant ASO3 is the most worrisome ingredient in the vaccine. The book Vaccine-A, by award-winning journalist Gary Matsumoto, discusses oil-based adjuvants, especially squalene. Referring to 1970s UCLA research, he reveals that “rats injected with either squalene or squalane all developed experimental encephalomyelitis, an MS-like disease”.
ASO3 contains squalene. This month physicians and advisers of the German military have nixed the approved H1N1 vaccines containing squalene and thimerosal, which is also a concern. Perhaps the powerful immune stimulation from squalene was on the mind of microbiologist Karl Weiss when he was interviewed for an article in the September 25th edition of the Montreal Gazette. Aaron Derfel reported that Weiss was certain that “For those who have been confirmed to have been infected by H1N1, getting the vaccine would not be a good idea. That's because their immune systems could overreact horribly.” This raises the question of how many Canadians would be at risk from the vaccine because they've already become infected with the virus, many without confirmation by testing or without realizing that they had an infection.
In his article, “How Vaccines Can Damage Your Brain”, retired neurosurgeon Russell Blaylock, M.D., CCN, declares same-day multiple injections criminal. He warns of research showing that a priming effect on brain immune cells by an initial vaccination may be followed by an extreme overreaction of these cells if a second vaccination is administered up to a year later. How much more overreaction will Canadians' brain cells suffer with the addition of yet another vaccine to the recommended schedules?
The aims of VRAN are threefold: fully informed consent to vaccination, an easily accessible and unbiased vaccine adverse event monitoring or event reporting system, and a national no-fault compensation plan. IMPACT, Immunization Monitoring Program ACTive, is conflicted by its sponsorship from a profession that earns wages through administration of vaccines and by its monitoring of opportunities to introduce new vaccines.
To Canada's shame, it's one of only a few developed countries without a national compensation plan. The excellent no-fault compensation report drafted many years ago by the Manitoba Law Reform Commission serves only to gather dust.